SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Jeevan Scientific Technology L

BSE: 538837 30 Sep 2025
Healthcare
₹ 37.78
Jeevan Scientific Technology Limited specializes in Healthcare Research- Analytics & Technology within the Healthcare sector.

Jeevan Scientific Technology L - Share Price & Details

Market Cap
₹63.4
High /Low
64.6 / 36.5
Stock P/E
1,268
Book Value
₹31.5
Dividend Yield
0.0
ROCE
2.73
ROE
₹0.1
Face Value
10.0
PEG Ratio
-15.4
EVEBITDA
₹10.4
Debt
20.6
CMP / FCF
-6.4
Debt to equity
₹0.41
NP Ann
0.05
High price all time
229.0
Piotroski score
₹5.0
Graham Number
7.63
No. Eq. Shares
1.58
Net CF
₹-0.30
Net profit
0.05
Price to book value
1.26
Interest Coverage
₹1.03
Low price all time
12.2
Industry PE
46.9
Reserves
₹34.1
Free Cash Flow
₹-5.96

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
Jeevan Scientific Technology LNANANANA63.41,268
Aspira Pathlab & Diagnostics LNANANANA60.725.3
VASUNDHARA RASAYANS LTDNANANANA58.214.8

Peer Comparison Chart


About Jeevan Scientific Technology L

Jeevan Scientific Technology Limited, with Security Code 538837, is a leading player in the Healthcare Research- Analytics & Technology industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Jeevan Scientific Technology Faces Financial Struggles Amid Significant Stock Volatility

(16 Sep 2025)
Jeevan Scientific Technology, a microcap in healthcare services, has hit a new 52-week low, reflecting significant volatility and underperformance.
Read more →

CDSCO Panel Nod To Phase I Clinical Trial of Anticancer Drug Bevacizumab by Jeevan Scientific

(14 Sep 2025)
New Delhi: Noting that the drug product is approved in the country of origin, the Subject Expert Committee (SEC), functional under the...
Read more →

NHRC Accepts Plea from Clinical Trial Subject Who Suffered Heart Attack

(10 Sep 2025)
In addition, the petition sought a direction to the Director General of Police to take necessary action on the two companies for duping...
Read more →

Jeevan Scientific Technology Reports Declining Sales and Profitability Challenges in June 2025 Results

(18 Aug 2025)
Jeevan Scientific Technology has reported its financial results for the quarter ending June 2025, showing significant operational challenges.
Read more →

Jeevan Scientific Technology reports consolidated net loss of Rs 3.10 crore in the June 2025 quarter

(18 Aug 2025)
Net loss of Jeevan Scientific Technology reported to Rs 3.10 crore in the quarter ended June 2025 as against net profit of Rs 1.09 crore...
Read more →

SecureKloud Technologies reports consolidated net loss of Rs 140.13 crore in the June 2025 quarter

(18 Aug 2025)
Net Loss of SecureKloud Technologies reported to Rs 140.13 crore in the quarter ended June 2025 as against net loss of Rs 6.37 crore during...
Read more →